ClinVar Genomic variation as it relates to human health
NM_000421.5(KRT10):c.466C>T (p.Arg156Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000421.5(KRT10):c.466C>T (p.Arg156Cys)
Variation ID: 14576 Accession: VCV000014576.19
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 17q21.2 17: 40822120 (GRCh38) [ NCBI UCSC ] 17: 38978372 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Aug 18, 2024 Oct 10, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000421.5:c.466C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000412.4:p.Arg156Cys missense NM_001379366.1:c.466C>T NP_001366295.1:p.Arg156Cys missense NC_000017.11:g.40822120G>A NC_000017.10:g.38978372G>A NG_008405.1:g.5492C>T P13645:p.Arg156Cys - Protein change
- R156C
- Other names
-
R10C
- Canonical SPDI
- NC_000017.11:40822119:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
KRT10 | - | - |
GRCh38 GRCh37 |
95 | 208 | |
KRT10-AS1 | - | - | - |
GRCh38 GRCh37 |
21 | 134 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (4) |
criteria provided, multiple submitters, no conflicts
|
Nov 3, 2022 | RCV000056496.15 | |
Pathogenic (1) |
criteria provided, single submitter
|
Oct 31, 2018 | RCV000763396.3 | |
Likely pathogenic (1) |
no assertion criteria provided
|
Feb 19, 2020 | RCV001849267.2 | |
KRT10-related disorder
|
Pathogenic (1) |
criteria provided, single submitter
|
Dec 6, 2022 | RCV003398521.4 |
Pathogenic (1) |
criteria provided, single submitter
|
Oct 10, 2023 | RCV003458335.1 | |
Pathogenic (1) |
no assertion criteria provided
|
Feb 1, 1994 | RCV004593967.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 31, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Epidermolytic hyperkeratosis 1
Ichthyosis, annular epidermolytic 1 Congenital reticular ichthyosiform erythroderma
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000894117.1
First in ClinVar: Mar 31, 2019 Last updated: Mar 31, 2019 |
|
|
Pathogenic
(Dec 30, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000490590.5
First in ClinVar: Oct 19, 2013 Last updated: Mar 04, 2023 |
Comment:
Located within the 1A domain helix initiation motif that is intolerant to change; variants affecting the residues at the ends of the central rod domains … (more)
Located within the 1A domain helix initiation motif that is intolerant to change; variants affecting the residues at the ends of the central rod domains of the keratin proteins (helix initiation and termination motifs) interfere with proper keratin intermediate filament assembly and function, resulting in skin fragility and/or hyperkeratosis (Chamcheu et al., 2011); Not observed at significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11990254, 17683385, 7509230, 7512983, 7526210, 28532675, 27722766, 22930352, 27535533, 31953843, 18033728, 24077912, 33081034) (less)
|
|
Pathogenic
(Dec 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
KRT10-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004119931.1
First in ClinVar: Nov 20, 2023 Last updated: Nov 20, 2023 |
Comment:
The KRT10 c.466C>T variant is predicted to result in the amino acid substitution p.Arg156Cys. This variant has been frequently reported in individuals with epidermolytic hyperkeratosis … (more)
The KRT10 c.466C>T variant is predicted to result in the amino acid substitution p.Arg156Cys. This variant has been frequently reported in individuals with epidermolytic hyperkeratosis (see for example Syder et al. 1994. PubMed ID: 7512983; Saeki et al. 2002. PubMed ID: 11990254; Haruna et al. 2007. PubMed ID: 17683385; Bygum et al. 2013. PubMed ID: 22930352; Severino-Freire et al. 2017. PubMed ID: 27722766; Kono et al. 2017. PubMed ID: 28532675; Cheng et al. 2020. PubMed ID: 31953843). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. (less)
|
|
Pathogenic
(Oct 10, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Epidermolytic nevus
Affected status: yes
Allele origin:
somatic
|
Clinical Genomics Laboratory, Washington University in St. Louis
Accession: SCV004176923.1
First in ClinVar: Dec 24, 2023 Last updated: Dec 24, 2023 |
Comment:
The KRT10 c.466C>T (Arg156Cys) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals affected by … (more)
The KRT10 c.466C>T (Arg156Cys) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in multiple individuals affected by ichthyosis (Paller AS et al., PMID: 7526210; Cheraghlou S et al., PMID: 32045015; Bygum A et al., PMID: 22930352; Kono M et al., PMID: 28532675; Syder AJ et al., PMID: 7512983; Mirza H et al., PMID: 26176760; Haruna K et al., PMID: 17683385; Rothnagel JA et al., PMID: 7509230; Diociaiuti A et al., PMID: 33081034). This variant has been reported in the ClinVar database as a pathogenic germline variant by multiple submitters and a likely pathogenic somatic variant by one submitter (ClinVar ID: 14576) and, in one case, in the cancer database COSMIC (ID: COSV99509833). This variant is absent from the general population, indicating that it is not a common variant (gnomAD v.3.1.2). The KRT10 c.466C>T (Arg156Cys) variant resides within an intermediate filament rod domain, amino acids 145-454, of KRT10 that is defined as a critical functional domain (Porter RM et al., PMID: 12711220; Rothnagel JA et al., PMID: 1380725). Functional studies show that this variant results in filament assembly disruption, leading to cell fragility (Syder AJ et al., PMID: 7512983; Mirza H et al., PMID: 26176760). Computational predictors indicate that the variant is damaging, evidence that correlates with impact to KRT10 function. Based on an internally developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the KRT10 c.466C>T (Arg156Cys) variant is classified as pathogenic. (less)
|
|
Pathogenic
(Nov 26, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002016400.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Nov 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV002119181.3
First in ClinVar: Mar 28, 2022 Last updated: Feb 14, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg156 amino acid residue in KRT10. Other variant(s) that disrupt this … (more)
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg156 amino acid residue in KRT10. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1381287, 21271994). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects KRT10 function (PMID: 7512983, 26176760). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT10 protein function. ClinVar contains an entry for this variant (Variation ID: 14576). This missense change has been observed in individual(s) with autosomal dominant KRT10 related conditions (PMID: 21271994, 22930352, 28532675). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 156 of the KRT10 protein (p.Arg156Cys). (less)
|
|
Pathogenic
(Feb 01, 1994)
|
no assertion criteria provided
Method: literature only
|
EPIDERMOLYTIC HYPERKERATOSIS 2A, AUTOSOMAL DOMINANT
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000035940.3
First in ClinVar: Apr 04, 2013 Last updated: Aug 18, 2024 |
Comment on evidence:
In an individual (EHK-K) with epidermolytic hyperkeratosis (EHK2A; 620150), Rothnagel et al. (1993) identified a heterozygous C-to-T transition in the KRT10 gene, resulting in an … (more)
In an individual (EHK-K) with epidermolytic hyperkeratosis (EHK2A; 620150), Rothnagel et al. (1993) identified a heterozygous C-to-T transition in the KRT10 gene, resulting in an arg10-to-cys (R10C) substitution. Rothnagel et al. (1993) concluded that there is a mutation hotspot within the 1A alpha-helical segment of KRT10 responsible for EHK. Mutations at residue 10 of the rod domain involved arginine to histidine (148080.0001), arginine to cysteine, and arginine to leucine (148080.0005). (It should be noted that arginine-125 in the KRT14 gene seems to be a similar mutation hotspot; in that case, epidermolysis bullosa simplex results from mutation in arginine-125 to histidine, cysteine, or leucine.) In a family (1013) with epidermolytic hyperkeratosis, Chipev et al. (1994) identified an R10C mutation in the beginning of the 1A rod domain of keratin-10. (less)
|
|
Likely pathogenic
(Feb 19, 2020)
|
no assertion criteria provided
Method: literature only
|
Epidermolytic acanthoma
Affected status: yes
Allele origin:
somatic
|
Yale Center for Mendelian Genomics, Yale University
Study: Yale Center for Mendelian Genomics
Accession: SCV002106701.1 First in ClinVar: Mar 28, 2022 Last updated: Mar 28, 2022 |
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
Epithelial Biology; Institute of Medical Biology, Singapore
Accession: SCV000087607.1
First in ClinVar: Oct 19, 2013 Last updated: Oct 19, 2013 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Mutations in KRT10 in epidermolytic acanthoma. | Cheraghlou S | Journal of cutaneous pathology | 2020 | PMID: 32045015 |
A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline. | Kono M | The Journal of investigative dermatology | 2017 | PMID: 28532675 |
Mutations Affecting Keratin 10 Surface-Exposed Residues Highlight the Structural Basis of Phenotypic Variation in Epidermolytic Ichthyosis. | Mirza H | The Journal of investigative dermatology | 2015 | PMID: 26176760 |
Generalized and naevoid epidermolytic ichthyosis in Denmark: clinical and mutational findings. | Bygum A | Acta dermato-venereologica | 2013 | PMID: 22930352 |
Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. | Arin MJ | The British journal of dermatology | 2011 | PMID: 21271994 |
Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity. | Syder AJ | The Journal of clinical investigation | 1994 | PMID: 7512983 |
Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. | Chipev CC | American journal of human genetics | 1994 | PMID: 7508181 |
A mutational hot spot in keratin 10 (KRT 10) in patients with epidermolytic hyperkeratosis. | Rothnagel JA | Human molecular genetics | 1993 | PMID: 7509230 |
The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. | Cheng J | Cell | 1992 | PMID: 1381287 |
Text-mined citations for rs58852768 ...
HelpRecord last updated Nov 03, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.